Mara Ferrandi Selected Research

adducin

11/2014	Rostafuroxin protects from podocyte injury and proteinuria induced by adducin genetic variants and ouabain.
1/2014	Lack of salt-inducible kinase 2 (SIK2) prevents the development of cardiac hypertrophy in response to chronic high-salt intake.
3/2011	Mutation in the beta adducin subunit causes tissue-specific damage to myogenic tone.
11/2010	Adducin- and ouabain-related gene variants predict the antihypertensive activity of rostafuroxin, part 1: experimental studies.
11/2010	Adducin- and ouabain-related gene variants predict the antihypertensive activity of rostafuroxin, part 2: clinical studies.
2/2010	alpha- and beta-Adducin polymorphisms affect podocyte proteins and proteinuria in rodents and decline of renal function in human IgA nephropathy.
5/2007	Adducin polymorphisms and the treatment of hypertension.
1/2007	Targeting Ouabain- and Adducin-dependent mechanisms of hypertension and cardiovascular remodeling as a novel pharmacological approach.
3/2006	Rostafuroxin: an ouabain antagonist that corrects renal and vascular Na+-K+- ATPase alterations in ouabain and adducin-dependent hypertension.
11/2004	Effect of Add1 gene transfer on blood pressure in reciprocal congenic strains of Milan rats.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mara Ferrandi Research Topics

Disease

12	Hypertension (High Blood Pressure) 03/2016 - 12/2002
7	Essential Hypertension 01/2021 - 11/2004
5	Hypertrophy 01/2014 - 08/2004
4	Heart Failure 01/2022 - 01/2007
3	Proteinuria 11/2014 - 02/2010
2	Cardiomegaly (Heart Hypertrophy) 01/2014 - 08/2004
1	Diabetic Cardiomyopathies 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Cardiotoxicity 01/2021
1	Cardiac Arrhythmias (Arrythmia) 01/2021
1	Neoplasms (Cancer) 01/2021
1	Ischemia 10/2016
1	Kidney Diseases (Kidney Disease) 10/2016
1	Reperfusion Injury 10/2016
1	Albuminuria 12/2014
1	Disease Progression 11/2014
1	Acute Kidney Injury (Acute Renal Failure) 03/2013
1	Low Cardiac Output 08/2011
1	IGA Glomerulonephritis (IGA Nephropathy) 02/2010
1	Renal Insufficiency (Renal Failure) 01/2009
1	Stroke (Strokes) 05/2007
1	Myocardial Infarction 05/2007
1	Cardiomyopathies (Cardiomyopathy) 03/2006
1	Hyperglycemia 12/2002

Drug/Important Bio-Agent (IBA)

11	adducinIBA 11/2014 - 12/2002
10	Ouabain (G Strophanthin)IBA 10/2016 - 08/2004
7	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2006
6	rostafuroxinIBA 01/2021 - 12/2002
5	Antihypertensive Agents (Antihypertensives)IBA 01/2021 - 12/2002
4	IstaroximeIBA 01/2022 - 01/2007
4	SaltsIBA 12/2014 - 05/2007
4	Adenosine Triphosphatases (ATPase)IBA 11/2014 - 03/2006
3	Pharmaceutical PreparationsIBA 01/2022 - 11/2010
3	CalciumIBA 08/2013 - 01/2007
3	SodiumIBA 01/2009 - 09/2005
2	nephrinIBA 12/2014 - 11/2014
2	DiureticsIBA 05/2007 - 12/2002
1	Sarcoplasmic Reticulum Calcium-Transporting ATPasesIBA 01/2022
1	human ERBB2 proteinIBA 01/2021
1	Trastuzumab (Herceptin)FDA Link 01/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021
1	AnthracyclinesIBA 01/2021
1	Losartan (Cozaar)FDA LinkGeneric 01/2021
1	Hormones (Hormone)IBA 10/2016
1	UromodulinIBA 12/2014
1	Therapeutic UsesIBA 11/2014
1	Phosphotransferases (Kinase)IBA 01/2014
1	Messenger RNA (mRNA)IBA 01/2014
1	phospholambanIBA 08/2013
1	Biomarkers (Surrogate Marker)IBA 03/2013
1	Furosemide (Lasix)FDA LinkGeneric 08/2011
1	Member 1 Solute Carrier Family 12IBA 08/2011
1	nasIBA 03/2011
1	Biological ProductsIBA 11/2010
1	Sodium-Potassium-Exchanging ATPase (Sodium, Potassium ATPase)IBA 01/2009
1	Protein Isoforms (Isoforms)IBA 01/2007
1	Calcium-Transporting ATPases (Ca2+ ATPase)IBA 01/2007
1	Cardiac GlycosidesIBA 03/2006
1	DigitoxigeninIBA 09/2005
1	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 12/2002
1	ReninIBA 12/2002
1	AldosteroneIBA 12/2002

Therapy/Procedure

8	Therapeutics 01/2021 - 03/2006
1	Nephrectomy 10/2016
1	Precision Medicine 03/2016